Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Nov;60(5):1216–1219. doi: 10.1172/JCI108875

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

E Ipp, R E Dobbs, V Harris, A Arimura, W Vale, R H Unger
PMCID: PMC372476  PMID: 908761

Abstract

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of pancreozymin-cholecystokinin on immunoreactive somatostatin release were studied in the isolated perfused dog pancreas. Gastrin at a concentration of 65 ng/ml and the octapeptide of pancreozymin-cholecystokinin at a concentration of 25 ng/ml produced a prompt, but transient statistically significant, twofold rise in mean somatostatin concentration. Secretion at a concentration of 0.3 U/ml and gastric inhibitory polypeptide concentration of 58 ng/ml produced a prompt two- to threefold rise in mean somatostatin release, which persisted throughout the perfusion period. With all four polypeptides the pattern of the somatostatin response resembled that of insulin. It appears that pancreatic somatostatin release is stimulated by gastrointestinal hormones that influence the secretion of insulin and glucagon.

Full text

PDF
1216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G., Christensen N. J., Christensen S. E., Hansen A. P., Iversen J., Lundbaek K., Seyer-Hansen K., Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. doi: 10.1016/s0140-6736(73)92873-0. [DOI] [PubMed] [Google Scholar]
  2. Bloom S. R., Mortimer C. H., Thorner M. O., Besser G. M., Hall R., Gomez-Pan A., Roy V. M., Russell R. C., Coy D. H., Kastin A. J. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet. 1974 Nov 9;2(7889):1106–1109. doi: 10.1016/s0140-6736(74)90869-1. [DOI] [PubMed] [Google Scholar]
  3. Boden G., Sivitz M. C., Owen O. E., Essa-Koumar N., Landor J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science. 1975 Oct 10;190(4210):163–165. doi: 10.1126/science.1166308. [DOI] [PubMed] [Google Scholar]
  4. Creutzfeldt W., Lankisch P. G., Fölsch U. R. Hemmung der Sekretin-und Cholezystokinin-Pankreozymin-induzierten Saft-und Enzymsekretion des Pankreas und der Gallenblasenkontraktion beim Menschen durch Somatostatin. Dtsch Med Wochenschr. 1975 May 16;100(20):1135–1138. [PubMed] [Google Scholar]
  5. DUPRE J. AN INTESTINAL HORMONE AFFECTING GLUCOSE DISPOSAL IN MAN. Lancet. 1964 Sep 26;2(7361):672–673. doi: 10.1016/s0140-6736(64)92481-x. [DOI] [PubMed] [Google Scholar]
  6. Dubois M. P. Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1340–1343. doi: 10.1073/pnas.72.4.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dupre J., Ross S. A., Watson D., Brown J. C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab. 1973 Nov;37(5):826–828. doi: 10.1210/jcem-37-5-826. [DOI] [PubMed] [Google Scholar]
  8. Floyd J. C., Jr, Fajans S. S., Conn J. W., Knopf R. F., Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966 Sep;45(9):1487–1502. doi: 10.1172/JCI105456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frame C. M., Davidson M. B., Sturdevant R. A. Effects of the octapeptide of cholecystokinin on insulin and glucagon secretion in the dog. Endocrinology. 1975 Sep;97(3):549–553. doi: 10.1210/endo-97-3-549. [DOI] [PubMed] [Google Scholar]
  10. Ipp E., Dobbs R. E., Arimura A., Vale W., Harris V., Unger R. H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iversen J., Miles D. W. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes. 1971 Jan;20(1):1–9. doi: 10.2337/diab.20.1.1. [DOI] [PubMed] [Google Scholar]
  12. Iversen J. Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest. 1971 Oct;50(10):2123–2136. doi: 10.1172/JCI106706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaneto A., Tasaka Y., Kosaka K., Nakao K. Stimulation of insulin secretion by the C-terminal tetrapeptide amide of gastrin. Endocrinology. 1969 May;84(5):1098–1106. doi: 10.1210/endo-84-5-1098. [DOI] [PubMed] [Google Scholar]
  14. Koerker D. J., Ruch W., Chideckel E., Palmer J., Goodner C. J., Ensinck J., Gale C. C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science. 1974 Apr 26;184(4135):482–484. doi: 10.1126/science.184.4135.482. [DOI] [PubMed] [Google Scholar]
  15. Konturek S. J., Tasler J., Obtulowicz W., Coy D. H., Schally A. V. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest. 1976 Jul;58(1):1–6. doi: 10.1172/JCI108438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Luft R., Efendic S., Hökfelt T., Johansson O., Arimura A. Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol. 1974 Dec;52(6):428–430. [PubMed] [Google Scholar]
  17. Meade R. C., Kneubuhler H. A., Schulte W. J., Barboriak J. J. Stimulation of insulin secretion by pancreozymin. Diabetes. 1967 Mar;16(3):141–144. doi: 10.2337/diab.16.3.141. [DOI] [PubMed] [Google Scholar]
  18. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Pancreatic immunoreactive somatostatin release. Proc Natl Acad Sci U S A. 1977 May;74(5):2140–2143. doi: 10.1073/pnas.74.5.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Response of pancreatic immunoreactive somatostatin to arginine. Life Sci. 1976 Dec 15;19(12):1957–1959. doi: 10.1016/0024-3205(76)90131-4. [DOI] [PubMed] [Google Scholar]
  20. Pederson R. A., Dryburgh J. R., Brown J. C. The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide. Can J Physiol Pharmacol. 1975 Dec;53(6):1200–1205. doi: 10.1139/y75-168. [DOI] [PubMed] [Google Scholar]
  21. Pfeiffer E. F., Telib M., Ammon J., Melani F., Ditschuneit H. Direkte Stimulierung der Insulin-Sekretion in vitro durch Sekretin. Dtsch Med Wochenschr. 1965 Sep 17;90(38):1663–1669. doi: 10.1055/s-0028-1113397. [DOI] [PubMed] [Google Scholar]
  22. Schauder P., McIntosh C., Arends J., Arnold R., Frerichs H., Creutzfeldt W. Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett. 1976 Oct 1;68(2):225–227. doi: 10.1016/0014-5793(76)80441-3. [DOI] [PubMed] [Google Scholar]
  23. Unger R. H., Ipp E., Schusdziarra V., Orci L. Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus. Life Sci. 1977 Jun 15;20(12):2081–2085. doi: 10.1016/0024-3205(77)90188-6. [DOI] [PubMed] [Google Scholar]
  24. Unger R. H., Ketterer H., Dupré J., Eisentraut A. M. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest. 1967 Apr;46(4):630–645. doi: 10.1172/JCI105565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES